Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

The Case for iBio Stock Is Real, but Leaves a Key Question Unanswered

By Chris Markoch, InvestorPlace Contributor

iBio has a long-standing relationship with the United States defense industry. But that hasn't enough to give IBIO stock a leg up in the Covid-19 race.

Buying Canopy Growth Seems Expensive Right Now

By Chris Markoch, InvestorPlace Contributor

After a month that gave cannabis stocks one catalyst after another, it's logical to want to buy CGC stock. That may be true, but caution is still advised.

Hexo Has to Show That This Time Is Different

By Chris Markoch, InvestorPlace Contributor

HEXO stock is down more than 50% in 2020. Its latest attempt at redefining itself as a CBD-infused drinks maker looks like a heavy lift.

If You Buy the Kensington Capital Stock Story, Be Ready to Sell the News

By Chris Markoch, InvestorPlace Contributor

Kensington Capital may offer a breakthrough in the quest for a better EV battery. But with four years until a product is available, you have to stay informed.

The Real Work For Fisker Is Just Beginning

By Chris Markoch, InvestorPlace Contributor

Fisker is the latest EV company to go public via a SPAC. But with the reverse merger completed, the heavy lifting for FSR stock has just begun.

Load More